Search Results - M Connock

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Sorafenib for the treatment of advanced hepatocellular carcinoma by M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld, D Moore

    Published in Health Technology Assessment (2010-05-01)
    Get full text
    Article


  2. 2

    Sorafenib for the treatment of advanced hepatocellular carcinoma by M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld, D Moore

    Published in Health Technology Assessment (2010-05-01)
    Get full text
    Article


  3. 3

    Infliximab for the treatment of acute exacerbations of ulcerative colitis by S Bryan, L Andronis, C Hyde, M Connock, A Fry-Smith, D Wang

    Published in Health Technology Assessment (2010-05-01)
    Get full text
    Article


  4. 4

    Infliximab for the treatment of acute exacerbations of ulcerative colitis by S Bryan, L Andronis, C Hyde, M Connock, A Fry-Smith, D Wang

    Published in Health Technology Assessment (2010-05-01)
    Get full text
    Article


  5. 5

    'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis by D Wang, M Connock, P Barton, A Fry-Smith, P Aveyard, D Moore

    Published in Health Technology Assessment (2008-02-01)
    Get full text
    Article


  6. 6

    Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia by R Edlin, M Connock, S Tubeuf, J Round, A Fry-Smith, C Hyde, W Greenheld

    Published in Health Technology Assessment (2010-05-01)
    Get full text
    Article


  7. 7

    Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling by M Connock, C Stevens, A Fry-Smith, S Jowett, D Fitzmaurice, D Moore, F Song

    Published in Health Technology Assessment (2007-10-01)
    Get full text
    Article


  8. 8

    Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis by M Connock, S Tubeuf, K Malottki, A Uthman, J Round, S Bayliss, C Meads, D Moore

    Published in Health Technology Assessment (2010-10-01)
    Get full text
    Article


  9. 9

    Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation by J Wilson, M Connock, F Song, G Yao, A Fry-Smith, J Raftery, D Peake

    Published in Health Technology Assessment (2005-07-01)
    Get full text
    Article


  10. 10

    A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1 by M Connock, A Juarez-Garcia, E Frew, A Mans, J Dretzke, A Fry-Smith, D Moore

    Published in Health Technology Assessment (2006-06-01)
    Get full text
    Article


  11. 11

    Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours by J Dretzke, J Round, M Connock, S Tubeuf, M Pennant, A Fry-Smith, C Hulme, C McCabe, C Meads

    Published in Health Technology Assessment (2010-10-01)
    Get full text
    Article


  12. 12

    Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation by M Connock, A Juarez-Garcia, S Jowett, E Frew, Z Liu, R Taylor, A Fry-Smith, E Day, N Lintzeris, T Roberts, A Burls, R Taylor

    Published in Health Technology Assessment (2007-03-01)
    Get full text
    Article


  13. 13

    The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review by M Connock, A Burls, E Frew, A Fry-Smith, A Juarez-Garcia, C McCabe, A Wailoo, K Abrams, N Cooper, A Sutton, A O'Hagan, D Moore

    Published in Health Technology Assessment (2006-07-01)
    Get full text
    Article


Search Tools: